لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Bakker NA, Westerlaan HE, Metzemaekers JD, van Dijk JM, Eshghi OS, Mooij JJ, Groen RJ, Bakker, Nicolaas A, Westerlaan, Henriette E, Metzemaekers, Jan D M, van Dijk, J Marc C, Eshghi, Omid S, Mooij, Jan Jakob A, Groen, Rob J M

المصدر: Acta Radiologica; Feb2010, Vol. 51 Issue 2, p226-232, 7p

مصطلحات موضوعية: ANGIOGRAPHY, ANEURYSMS, DIAGNOSTIC imaging, MEDICAL photography, CEREBROVASCULAR disease

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic., Micheva I; Hematology Clinic, University Hospital 'St. Marina,' Medical University, Varna, Bulgaria., Usenko G; City Clinical Hospital #4 of Dnipro, Dnipro, Ukraine., Mikala G; Department of Hematology and Stem Cell Transplantation, National Institute for Hematology and Infectious Diseases, South Pest Central Hospital, Budapest, Hungary., Masszi T; Department of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary., Simeonova K; Specialized Hospital for Active Treatment of Hematological Diseases, Sofia, Bulgaria., Thuresson M; Oncopeptides AB, Stockholm, Sweden., Huledal G; Oncopeptides AB, Stockholm, Sweden., Norin S; Oncopeptides AB, Stockholm, Sweden., Bakker NA; Oncopeptides AB, Stockholm, Sweden., Minarik J; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic. Electronic address: abretina@email.cz.

المصدر: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jun; Vol. 24 (6), pp. e267-e275.e2. Date of Electronic Publication: 2024 Feb 23.

نوع المنشور: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/drug therapy , Multiple Myeloma*/pathology , Cross-Over Studies*, Humans ; Male ; Female ; Middle Aged ; Aged ; Phenylalanine/analogs & derivatives ; Phenylalanine/administration & dosage ; Phenylalanine/pharmacokinetics ; Adult ; Melphalan/administration & dosage ; Melphalan/therapeutic use ; Melphalan/analogs & derivatives ; Neoplasm Recurrence, Local/drug therapy ; Administration, Intravenous ; Aged, 80 and over ; Treatment Outcome ; Infusions, Intravenous

المؤلفون: Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic. pour.ludek@fnbrno.cz., Szarejko M; University Clinical Centre, Department of Hematology and Transplantology, Gdansk., Bila J; Clinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade., Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo., Spicka I; 1^st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic., Maisnar V; 4^th Department of Medicine - Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic., Jurczyszyn A; Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Faculty of Medicine, Krakow., Grudeva-Popova Z; Department of Clinical Oncology, Medical Faculty, Medical University of Plovdiv, Plovdic, Bulgaria., Hájek R; Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Usenko G; City Clinical Hospital No. 4 of Dnipro City Council, Dnipro, Ukraine., Thuresson M; Oncopeptides AB, Stockholm., Norin S; Oncopeptides AB, Stockholm., Jarefors S; Oncopeptides AB, Stockholm., Bakker NA; Oncopeptides AB, Stockholm., Richardson PG; Dana-Farber Cancer Institute, Boston, MA., Mateos MV; Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca.

المصدر: Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 895-905. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal* , Hematopoietic Stem Cell Transplantation* , Melphalan*/analogs & derivatives , Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy , Neoplasms, Plasma Cell* , Neutropenia* , Phenylalanine*/analogs & derivatives, Humans ; Dexamethasone/therapeutic use ; Proteasome Inhibitors ; Transplantation, Autologous ; United States ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway., Ludwig H; Medical Department Center for Oncology, Hematology and Palliative Medicine, Wilhelminen Cancer Research Institute, Vienna, Austria., Mateos MV; Institute of Cancer Molecular and Cellular Biology, University Hospital of Salamanca, Salamanca, Spain., Larocca A; Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy., Abdulhaq H; Department of Hematology and Oncology, University of California, San Francisco, Fresno, California, USA., Norin S; Clinical Science, Oncopeptides AB, Stockholm, Sweden., Thuresson M; Biostatistics, Oncopeptides AB, Stockholm, Sweden., Bakker NA; Clinical Science, Oncopeptides AB, Stockholm, Sweden., Richardson PG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Sonneveld P; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

المصدر: European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 402-411. Date of Electronic Publication: 2023 Nov 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy , Hematopoietic Stem Cell Transplantation*, Melphalan/*analogs & derivatives , Phenylalanine/*analogs & derivatives , Thalidomide/*analogs & derivatives, Humans ; Melphalan/therapeutic use ; Alkylating Agents/therapeutic use ; Dexamethasone/adverse effects ; Transplantation, Autologous ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria, Santander. ocioem@unican.es., Efebera YA; Department of Hematology/Oncology, Division of Blood and Marrow Transplant and Cellular Therapy, OhioHealth, Columbus, OH, USA and OhioHealth, Columbus, OH., Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Straub J; Všeobecná fakultní nemocnice, Prague, Czech Republic., Maisnar V; Fourth Department of Medicine - Hematology, Charles University Hospital, Hradec Králové, Czech Republic., Eveillard JR; Hôpital Morvan, Brest., Karlin L; Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre-Bénite., Mateos MV; Hospital Clinico Universitario de Salamanca/IBSAL/CIC, Salamanca., Oriol A; Institut Català d'Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona., Ribrag V; Drug Development Department (DITEP), Gustave Roussy, Université Paris-Saclay, Villejuif., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Norin S; Oncopeptides AB, Stockholm., Obermüller J; Oncopeptides AB, Stockholm., Bakker NA; Oncopeptides AB, Stockholm., Pour L; Fakultní nemocnice Brno, Brno, Czech Republic.

المصدر: Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 867-876. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal* , Melphalan*/analogs & derivatives , Multiple Myeloma*/diagnosis , Multiple Myeloma*/drug therapy , Neoplasms, Plasma Cell* , Neutropenia*/chemically induced , Phenylalanine*/analogs & derivatives , Thrombocytopenia*, Humans ; Bortezomib/therapeutic use ; Dexamethasone/therapeutic use ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Schjesvold FH; Oslo Myeloma Center, Department of Hematology, Oslo University Hospital and KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway. fredrikschjesvold@gmail.com., Ludwig H; Department of Medicine I, Center for Medical Oncology and Hematology with Outpatient Department and Palliative Care, Wilhelminen Cancer Research Institute, Vienna., Delimpasi S; Bone Marrow Transplantation Unit and Department of Hematology, Evangelismos Hospital, Athens, Greece., Robak P; Department of Hemato-Oncology, University Hospital Ostrava, Ostrava, Czech Republic., Coriu D; University of Medicine and Pharmacy 'Carol Davila', Center of Hematology and Bone Marrow Transplantation, Fundeni Clinical Institute, Bucharest, Romania., Tomczak W; Department of Hemato-Oncology and Bone Marrow Transplantation, Medical University of Lublin., Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Babak Myeloma Group, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Spicka I; 1st Department of Medicine - Department of Hematology, First Faculty of Medicine, Charles University and General Hospital in Prague, Prague, Czech Republic., Dimopoulos MA; Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece., Masszi T; Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Chernova NG; National Research Center for Haematology, Moscow, Russia., Sandberg A; Oncopeptides AB, Stockholm, Sweden., Thuresson M; Oncopeptides AB, Stockholm, Sweden., Norin S; Oncopeptides AB, Stockholm, Sweden., Bakker NA; Oncopeptides AB, Stockholm, Sweden., Mateos MV; Hospital Clínico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain., Richardson PG; Dana-Farber Cancer Institute, Boston, MA., Sonneveld P; Erasmus MC Cancer Institute, Rotterdam.

المصدر: Haematologica [Haematologica] 2024 Feb 29. Date of Electronic Publication: 2024 Feb 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE